{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:19:10Z","timestamp":1761895150040},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2010,8,24]],"date-time":"2010-08-24T00:00:00Z","timestamp":1282608000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s10067-010-1553-9","type":"journal-article","created":{"date-parts":[[2010,8,23]],"date-time":"2010-08-23T07:46:09Z","timestamp":1282549569000},"page":"1465-1467","source":"Crossref","is-referenced-by-count":41,"title":["A case of refractory adult-onset Still\u2019s disease successfully controlled with tocilizumab and a review of the literature"],"prefix":"10.1007","volume":"29","author":[{"given":"Katja","family":"Perdan-Pirkmajer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonja","family":"Praprotnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matija","family":"Tom\u0161i\u010d","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,8,24]]},"reference":[{"key":"1553_CR1","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.berh.2008.08.006","volume":"22","author":"B Fautrel","year":"2008","unstructured":"Fautrel B (2008) Adult-onset Still\u2019s disease. Best Pract Res Clin Rheumatol 22:773\u2013792","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1553_CR2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2165\/00003495-200868030-00005","volume":"68","author":"A Kontzias","year":"2008","unstructured":"Kontzias A, Efthimiou P (2008) Adult-onset Still\u2019s disease: pathogenesis, clinical manifestations and therapeutic advances. Drugs 68:319\u2013337","journal-title":"Drugs"},{"key":"1553_CR3","first-page":"424","volume":"29","author":"M Yamaguchi","year":"1992","unstructured":"Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H (1992) Preliminary criteria for classification of adult Still\u2019s disease. J Rheumatol 29:424\u2013430","journal-title":"J Rheumatol"},{"key":"1553_CR4","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1002\/art.10620","volume":"46","author":"M Iwamoto","year":"2002","unstructured":"Iwamoto M, Nara H, Hirata D, Minota S, Nishimoto N, Yoshizaki K (2002) Humanized monoclonal anti-interleukin-6 receptor antibody for treatment of intractable adult-onset Still\u2019s disease. Arthritis Rheum 46:3388\u20133389","journal-title":"Arthritis Rheum"},{"key":"1553_CR5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ard.2008.088179","volume":"68","author":"M Bandt De","year":"2009","unstructured":"De Bandt M, Saint-Marcoux B (2009) Tocilizumab for multi-refractory adult-onset Still\u2019s disease. Ann Rheum Dis 68:153\u2013154","journal-title":"Ann Rheum Dis"},{"key":"1553_CR6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10165-008-0116-2","volume":"19","author":"H Nakahara","year":"2009","unstructured":"Nakahara H, Mima T, Yoshio-Hoshino N, Matsushita M, Hashimoto J, Nishimoto N (2009) A case report of a patient with refractory adult-onset Still\u2019s disease who was successfully treated with tocilizumab over 6\u00a0years. Mod Rheumatol 19:69\u201372","journal-title":"Mod Rheumatol"},{"key":"1553_CR7","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s10067-009-1097-z","volume":"28","author":"K Matsumoto","year":"2009","unstructured":"Matsumoto K, Nagashima T, Takatori S, Kawahara Y, Yagi M, Iwamoto M et al (2009) Glucocorticoid and cyclosporine refractory adult onset Still\u2019s disease successfully treated with tocilizumab. Clin Rheumatol 28:485\u2013487","journal-title":"Clin Rheumatol"},{"key":"1553_CR8","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20050473","volume":"201","author":"V Pascual","year":"2005","unstructured":"Pascual V, Allantaz F, Arce E, Punaro M, Banchereau J (2005) Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med 201:1479\u20131486","journal-title":"J Exp Med"},{"key":"1553_CR9","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/BOR.0b013e32832f1445","volume":"21","author":"F Benedetti De","year":"2009","unstructured":"De Benedetti F (2009) Targeting interleukin-6 in pediatric rheumatic diseases. Curr Opin Rheumatol 21:533\u2013537","journal-title":"Curr Opin Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-010-1553-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-010-1553-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-010-1553-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:51:43Z","timestamp":1559119903000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-010-1553-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,24]]},"references-count":9,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1553"],"URL":"https:\/\/doi.org\/10.1007\/s10067-010-1553-9","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,24]]}}}